MicroRNAs: Key players in the immune system, differentiation, tumorigenesis and cell death

Oncogene

Volumn 27, Issue 45, 2008, Pages 5959-5974

  Schickel, R ^a   Boyerinas, B ^a   Park, S M ^a   Peter, M E ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Apoptosis; miRNA; OncomiRs; Tumor progression

Indexed keywords

CASPASE; MICRORNA; PROTEIN BCL 2;

APOPTOSIS; BIOGENESIS; CARCINOGENESIS; CELL DEATH; CELL DIFFERENTIATION; HEMATOPOIESIS; HUMAN; IMMUNE SYSTEM; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; CELL DEATH; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HEMATOPOIESIS; HUMANS; IMMUNE SYSTEM; MICRORNAS; NEOPLASMS; ONCOGENES; RNA, NEOPLASM;

EID: 53549097349     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.274     Document Type: Review

References (208)

1. Abbott AL, Alvarez-Saavedra E, Miska EA, Lau NC, Bartel DP, Horvitz HR et al. (2005). The let-7 MicroRNA family members mir-48, mir-84, and mir-241 function together to regulate developmental timing in Caenorhabditis elegans. Dev Cell 9: 403-414.
2. Abe N, Watanabe T, Suzuki Y, Matsumoto N, Masaki T, Mori T et al. (2003). An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue. Br J Cancer 89: 2104-2109.
3. Adachi M, Suematsu S, Suda T, Watanabe D, Fukuyama H, Ogasawara J et al. (1996). Enhanced and accelerated lymphoproliferation in Fas-null mice. Proc Natl Acad Sci USA 93: 2131-2136.
4. Akao Y, Nakagawa Y, Kitade Y, Kinoshita T, Naoe T. (2007). Downregulation of microRNAs-143 and -145 in B-cell malignancies. Cancer Sci 98: 1914-1920.
5. Akao Y, Nakagawa Y, Naoe T. (2006). let-7 MicroRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 29: 903-906.
6. Algeciras-Schimnich A, Barnhart BC, Peter ME. (2002). Apoptosis-independent functions of killer caspases. Curr Opin Cell Biol 14: 721-726.
7. Algeciras-Schimnich A, Pietras EM, Barnhart BC, Legembre P, Vijayan S, Holbeck SL et al. (2003). Two CD95 tumor classes with different sensitivities to antitumor drugs. Proc Natl Acad Sci USA 100: 11445-11450.
8. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S et al. (2008). MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27: 2128-2136.
9. Baehrecke EH. (2003). miRNAs: micro managers of programmed cell death. Curr Biol 13: R473-R475.
10. Barnhart BC, Alappat EC, Peter ME. (2003). The CD95 type I/type II model. Semin Immunol 15: 185-193.
11. Barry M, Heibein JA, Pinkoski MJ, Lee SF, Moyer RW, Green DR et al. (2000). Granzyme B short-circuits the need for caspase 8 activity during granule-mediated cytotoxic T-lymphocyte killing by directly cleaving Bid. Mol Cell Biol 20: 3781-3794.
12. Bartel DP. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
13. Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, Li MZ et al. (2003). Dicer is essential for mouse development. Nat Genet 35: 215-217.
14. Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, Love RE et al. (2007). p53-Mediated activation of miRNA34candidate tumor-suppressor genes. Curr Biol 17: 1298-1307.
15. Bouillet P, Metcalf D, Huang DC, Tarlinton DM, Kay TW, Kontgen F et al. (1999). Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286: 1735-1738.
16. Bouillet P, Purton JF, Godfrey DI, Zhang LC, Coultas L, Puthalakath H et al. (2002). BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 415: 922-926.
17. Boyerinas B, Park SM, Shomron N, Hedegaard MM, Vinther J, Andersen JA et al. (2008). Identification of Let-7-regulated oncofetal genes. Cancer Res 68: 2587-2591.
18. Brabletz T, Jung A, Hlubek F, Lohberg C, Meiler J, Suchy U et al. (1999). Negative regulation of CD4 expression in T cells by the transcriptional repressor ZEB. Int Immunol 11: 1701-1708.
19. Bredenkamp N, Seoighe C, Illing N. (2007). Comparative evolutionary analysis of the FoxG1 transcription factor from diverse vertebrates identifies conserved recognition sites for microRNA regulation. Dev Genes Evol 217: 227-233.
20. Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM. (2003). bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113: 25-36.
21. Brueckner B, Stresemann C, Kuner R, Mund C, Musch T, Meister M et al. (2007). The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. Cancer Res 67: 1419-1423.
22. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al. (2002). Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99: 15524-15529.
23. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE et al. (2005). A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353: 1793-1801.
24. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S et al. (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101: 2999-3004.
25. Care A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P et al. (2007). MicroRNA-133 controls cardiac hypertrophy. Nat Med 13: 613-618.
26. Castro JE, Listman JA, Jacobson BA, Wang Y, Lopez PA, Ju S et al. (1996). Fas modulation of apoptosis during negative selection of thymocytes. Immunity 5: 617-627.
27. Chalfie M, Horvitz HR, Sulston JE. (1981). Mutations that lead to reiterations in the cell lineages of C.elegans. Cell 24: 59-69.
28. Chan JA, Krichevsky AM, Kosik KS. (2005). MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65: 6029-6033.
29. Chang J, Nicolas E, Marks D, Sander C, Lerro A, Buendia MA et al. (2004). miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol 1: 106-113.
30. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH et al. (2007). Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26: 745-752.
31. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM et al. (2008). Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 40: 43-50.
32. Chen CZ, Li L, Lodish HF, Bartel DP. (2004). MicroRNAs modulate hematopoietic lineage differentiation. Science 303: 83-86.
33. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM et al. (2006). The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38: 228-233.
34. Chen Y, Gorski DH. (2008). Regulation of angiogenesis through a microRNA (miR-130a) that downregulates antiangiogenic homeobox genes GAX and HOXA5. Blood 111: 1217-1226.
35. Cheng AM, Byrom MW, Shelton J, Ford LP. (2005). Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 33: 1290-1297.
36. Chiappetta G, Bandiera A, Berlingieri MT, Visconti R, Manfioletti G, Battista S et al. (1995). The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. Oncogene 10: 1307-1314.
37. Ciafre SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G et al. (2005). Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334: 1351-1358.
38. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M et al. (2005). miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102: 13944-13949.
39. Corney DC, Flesken-Nikitin A, Godwin AK, Wang W, Nikitin AY. (2007). MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res 67: 8433-8438.
40. Corsten MF, Miranda R, Kasmieh R, Krichevsky AM, Weissleder R, Shah K. (2007). MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res 67: 8994-9000.
41. Costinean S, Zanesi N, Pekarsky Y, Tili E, Volinia S, Heerema N et al. (2006). Pre-B cell proliferation and lymphoblastic leukemia/highgrade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci USA 103: 7024-7029.
42. Coultas L, Strasser A. (2003). The role of the Bcl-2 protein family in cancer. Semin Cancer Biol 13: 115-123.
43. Cretney E, Uldrich AP, Berzins SP, Strasser A, Godfrey DI, Smyth MJ. (2003). Normal thymocyte negative selection in TRAIL-deficient mice. J Exp Med 198: 491-496.
44. Cui Q, Yu Z, Purisima EO, Wang E. (2006). Principles of microRNA regulation of a human cellular signaling network. Mol Syst Biol 2: 46.
45. Cullen BR. (2004). Transcription and processing of human microRNA precursors. Mol Cell 16: 861-865.
46. Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, Wentzel E et al. (2006). Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 38: 1060-1065.
47. Eis PS, Tam W, Sun L, Chadburn A, Li Z, Gomez MF et al. (2005). Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci USA 102: 3627-3632.
48. Enders A, Bouillet P, Puthalakath H, Xu Y, Tarlinton DM, Strasser A. (2003). Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells. J Exp Med 198: 1119-1126.
49. Engels BM, Hutvagner G. (2006). Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene 25: 6163-6169.
50. Erickson SL, de Sauvage FJ, Kikly K, Carver-Moore K, Pitts-Meek S, Gillett N et al. (1994). Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 372: 560-563.
51. Esau C, Davis S, Murray SF, Yu XX, Pandey SK, PearMet al. (2006). miR-122 Regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3: 87-98.
52. Esau C, Kang X, Peralta E, Hanson E, Marcusson EG, Ravichandran LV et al. (2004). MicroRNA-143 regulates adipocyte differentiation. J Biol Chem 279: 52361-52365.
53. Esquela-Kerscher A, Slack FJ. (2006). Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
54. Esquela-Kerscher A, Trang P, Wiggins JF, Patrawala L, Cheng A, Ford L et al. (2008). The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle 7: 759-764.
55. Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E et al. (2007). MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci USA 104: 15805-15810.
56. Fazi F, Rosa A, Fatica A, Gelmetti V, De Marchis ML, Nervi C et al. (2005). A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 123: 819-831.
57. Felli N, Fontana L, Pelosi E, Botta R, Bonci D, Facchiano F et al. (2005). MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci USA 102: 18081-18086.
58. Fontana L, Pelosi E, Greco P, Racanicchi S, Testa U, Liuzzi F et al. (2007). MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nat Cell Biol 9: 775-787.
59. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH. (2008). Programmed cell death 4(PDCD 4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 283: 1026-1033.
60. Fukao T, Fukuda Y, Kiga K, Sharif J, Hino K, Enomoto Y et al. (2007). An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. Cell 129: 617-631.
61. Galardi S, Mercatelli N, Giorda E, Massalini S, Frajese GV, Ciafre SA et al. (2007). miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem 282: 23716-23724.
62. Garzon R, Pichiorri F, Palumbo T, Iuliano R, Cimmino A, Aqeilan R et al. (2006). MicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sci USA 103: 5078-5083.
63. Gauwerky CE, Huebner K, Isobe M, Nowell PC, Croce CM. (1989). Activation of MYC in a masked t(8;17) translocation results in an aggressive B-cell leukemia. Proc Natl Acad Sci USA 86: 8867-8871.
64. Georgantas III RW, Hildreth R, Morisot S, Alder J, Liu CG, Heimfeld S et al. (2007). CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci USA 104: 2750-2755.
65. Giannini G, Kim CJ, Di Marcotullio L, Manfioletti G, Cardinali B, Cerignoli F et al. (2000). Expression of the HMGI(Y) gene products in human neuroblastic tumours correlates with differentiation status. Br J Cancer 83: 1503-1509.
66. Gillies JK, Lorimer IA. (2007). Regulation of p27Kip1 by miRNA 221/222 in glioblastoma. Cell Cycle 6: 2005-2009.
67. Gironella M, Seux M, Xie MJ, Cano C, Tomasini R, Gommeaux J et al. (2007). Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc Natl Acad Sci USA 104: 16170-16175.
68. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, Bassi P et al. (2007). Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 25: 387-392.
69. Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, Liu CG et al. (2007). Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 67: 6092-6099.
70. Grandori C, Cowley SM, James LP, Eisenman RN. (2000). The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 16: 653-699.
71. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshild G et al. (2008). The microRNA-200 family and miR-205 regulate epithelial-mesenchymal transition by targeting the E-cadherin repressors, ZEB1 and SIP1. Nature Cell Biol 10: 593-601.
72. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. (2007). MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27: 91-105.
73. Guo Y, Chen Y, Ito H, Watanabe A, Ge X, Kodama T et al. (2006). Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma. Gene 384: 51-61.
74. Harris TA, Yamakuchi M, Ferlito M, Mendell JT, Lowenstein CJ. (2008). MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci USA 105: 1516-1521.
75. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S et al. (2005). A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65: 9628-9632.
76. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S et al. (2005a). The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 102: 19075-19080.
77. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y et al. (2007). A microRNA component of the p53 tumour suppressor network. Nature 447: 1130-1134.
78. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S et al. (2005b). A microRNA polycistron as a potential human oncogene. Nature 435: 828-833.
79. Hebert C, Norris K, Scheper MA, Nikitakis N, Sauk JJ. (2007). High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma. Mol Cancer 6: 5.
80. Hornstein E, Mansfield JH, Yekta S, Hu JK, Harfe BD, McManus MT et al. (2005). The microRNA miR-196 acts upstream of Hoxb8 and Shh in limb development. Nature 438: 671-674.
81. Hossain A, Kuo MT, Saunders GF. (2006). Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol Cell Biol 26: 8191-8201.
82. Hughes PD, Belz GT, Fortner KA, Budd RC, Strasser A, Bouillet P. (2008). Apoptosis regulators Fas and Bim cooperate in shutdown of chronic immune responses and prevention of autoimmunity. Immunity 28: 197-205.
83. Hutcheson J, Scatizzi JC, Siddiqui AM, Haines III GK, Wu T, Li QZ et al. (2008). Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity. Immunity 28: 206-217.
84. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S et al. (2005). MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070.
85. Janz S. (2006). Myc translocations in B cell and plasma cell neoplasms. DNA Repair (Amst) 5: 1213-1224.
86. Joglekar MV, Parekh VS, Mehta S, Bhonde RR, Hardikar AA. (2007). MicroRNA profiling of developing and regenerating pancreas reveal post-transcriptional regulation of neurogenin3. Dev Biol 311: 603-612.
87. Johnson CD, Esquela-Kerscher A, Stefani G, Byrom M, Kelnar K, Ovcharenko D et al. (2007). The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 67: 7713-7722.
88. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A et al. (2005). RAS is regulated by the let-7 microRNA family. Cell 120: 635-647.
89. Johnston RJ, Hobert O. (2003). A microRNA controlling left/right neuronal asymmetry in Caenorhabditis elegans. Nature 426: 845-849.
90. Karin M, Lawrence T, Nizet V. (2006). Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 124: 823-835.
91. Kawasaki H, Taira K. (2004). MicroRNA-196 inhibits HOXB8 expression in myeloid differentiation of HL60 cells. Nucleic Acids Symp Ser (Oxf) 48: 211-212.
92. Kim VN. (2005). MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 6: 376-385.
93. Kishimoto H, Surh CD, Sprent J. (1998). A role for Fas in negative selection of thymocytes in vivo. J Exp Med 187: 1427-1438.
94. Kluiver J, Haralambieva E, de Jong D, Blokzijl T, Jacobs S, Kroesen BJ et al. (2006). Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. Genes Chromosomes Cancer 45: 147-153.
95. Kluiver J, Poppema S, de Jong D, Blokzijl T, Harms G, Jacobs S et al. (2005). BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol 207: 243-249.
96. Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, Sharp PA et al. (2008). Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci USA 105: 3903-3908.
97. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T. (2007). Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 39: 673-677.
98. Kutay H, Bai S, Datta J, Motiwala T, Pogribny I, Frankel W et al. (2006). Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 99: 671-678.
99. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. (2001). Identification of novel genes coding for small expressed RNAs. Science 294: 853-858.
100. Lai EC. (2002). Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet 30: 363-364.
101. Lamhamedi-Cherradi SE, Zheng SJ, Maguschak KA, Peschon J, Chen YH. (2003). Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice. Nat Immunol 4: 255-260.
102. Landais S, Landry S, Legault P, Rassart E. (2007). Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. Cancer Res 67: 5699-5707.
103. Lawrie CH, Soneji S, Marafioti T, Cooper CD, Palazzo S, Paterson JC et al. (2007). MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer 121: 1156-1161.
104. le Sage C, Nagel R, Egan DA, Schrier M, Mesman E, Mangiola A et al. (2007). Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J 26: 3699-3708.
105. Lee EJ, Gusev Y, Jiang J, Nuovo GJ, Lerner MR, Frankel WL et al. (2007). Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer 120: 1046-1054.
106. Lee HJ, Palkovits M, Young III WS. (2006a). miR-7b, a microRNA up-regulated in the hypothalamus after chronic hyperosmolar stimulation, inhibits Fos translation. Proc Natl Acad Sci USA 103: 15669-15674.
107. Lee KH, Feig C, Tchikov V, Schickel R, Hallas C, Schutze S et al. (2006b). The role of receptor internalization in CD95 signaling. EMBO J 25: 1009-1023.
108. Lee RC, Feinbaum RL, Ambros V. (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843-854.
109. Lee YS, Dutta A. (2007). The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 21: 1025-1030.
110. Lehmann U, Hasemeier B, Christgen M, Muller M, Romermann D, Langer F et al. (2008). Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J Pathol 214: 17-24.
111. Lewis BP, Burge CB, Bartel DP. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
112. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. (2003). Prediction of mammalian microRNA targets. Cell 115: 787-798.
113. Li H, Zhu H, Xu CJ, Yuan J. (1998). Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491-501.
114. Li QJ, Chau J, Ebert PJ, Sylvester G, Min H, Liu G et al. (2007). miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129: 147-161.
115. Linsley PS, Schelter J, Burchard J, Kibukawa M, Martin MM, Bartz SR et al. (2007). Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol Cell Biol 27: 2240-2252.
116. Liu CG, Calin GA, Meloon B, Gamliel N, Sevignani C, Ferracin M et al. (2004). An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci USA 101: 9740-9744.
117. Loffler D, Brocke-Heidrich K, Pfeifer G, Stocsits C, Hackermuller J, Kretzschmar AK et al. (2007). Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood 110: 1330-1333.
118. Lu J, Getz G, Miska EA, varez-Saavedra E, Lamb J, Peck D et al. (2005). MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
119. Lu L, Katsaros D, de la Longrais IA, Sochirca O, Yu H. (2007a). Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis. Cancer Res 67: 10117-10122.
120. Lu Y, Thomson JM, Wong HY, Hammond SM, Hogan BL. (2007b). Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. Dev Biol 310: 442-453.
121. Lui WO, Pourmand N, Patterson BK, Fire A. (2007). Patterns of known and novel small RNAs in human cervical cancer. Cancer Res 67: 6031-6043.
122. Lukiw WJ, Pogue AI. (2007). Induction of specific micro RNA (miRNA) species by ROS-generating metal sulfates in primary human brain cells. J Inorg Biochem 101: 1265-1269.
123. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. (1998). Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481-490.
124. Ma L, Teruya-Feldstein J, Weinberg RA. (2007). Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449: 682-688.
125. Marton S, Garcia MR, Robello C, Persson H, Trajtenberg F, Pritsch O et al. (2008). Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis. Leukemia 22: 330-338.
126. Masaki S, Ohtsuka R, Abe Y, Muta K, Umemura T. (2007). Expression patterns of microRNAs 155 and 451 during normal human erythropoiesis. Biochem Biophys Res Commun 364: 509-514.
127. Matsubara H, Takeuchi T, Nishikawa E, Yanagisawa K, Hayashita Y, Ebi H et al. (2007). Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. Oncogene 26: 6099-6105.
128. Mayr C, Hemann MT, Bartel DP. (2007). Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315: 1576-1579.
129. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. (2007a). MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658.
130. Meng F, Henson R, Wehbe-Janek H, Smith H, Ueno Y, Patel T. (2007b). The microRNA let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes. J Biol Chem 282: 8256-8264.
131. Metzler M, Wilda M, Busch K, Viehmann S, Borkhardt A. (2004). High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer 39: 167-169.
132. Michael MZ, SM OC, van Holst Pellekaan NG, Young GP, James RJ. (2003). Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 1: 882-891.
133. Miyazawa J, Mitoro A, Kawashiri S, Chada KK, Imai K. (2004). Expression of mesenchyme-specific gene HMGA2 in squamous cell carcinomas of the oral cavity. Cancer Res 64: 2024-2029.
134. Mott JL, Kobayashi S, Bronk SF, Gores GJ. (2007). mir-29 Regulates Mcl-1 protein expression and apoptosis. Oncogene 26: 6133-6140.
135. Naguibneva I, Ameyar-Zazoua M, Polesskaya A, Ait-Si-Ali S, Groisman R, Souidi M et al. (2006). The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation. Nat Cell Biol 8: 278-284.
136. Newman MA, Thomson JM, Hammond S. (2008). Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing. RNA; 19 January 2008, e-pub ahead of print.
137. Nielsen CB, Shomron N, Sandberg R, Hornstein E, Kitzman J, Burge CB. (2007). Determinants of targeting by endogenous and exogenous microRNA and siRNAs. RNA 13: 1894-1910.
138. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. (2007). MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci USA 104: 1604-1609.
139. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. (2005). c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839-843.
140. O'Rourke JR, Georges SA, Seay HR, Tapscott SJ, McManus MT, Goldhamer DJ et al. (2007). Essential role for Dicer during skeletal muscle development. Dev Biol 311: 359-368.
141. Ota A, Tagawa H, Karnan S, Tsuzuki S, Karpas A, Kira S et al. (2004). Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res 64: 3087-3095.
142. Page DM, Roberts EM, Peschon JJ, Hedrick SM. (1998). TNF receptor-deficient mice reveal striking differences between several models of thymocyte negative selection. J Immunol 160: 120-133.
143. Park SM, Gaur AB, Lengyel E, Peter ME. (2008). The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors, ZEB1 and ZEB2. Genes Dev 22: 894-907.
144. Park SM, Shell S, Radjabi AR, Schickel R, Feig C, Boyerinas B et al. (2007). Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2. Cell Cycle 6: 2585-2590.
145. Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI, Maller B et al. (2000). Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408: 86-89.
146. Pekarsky Y, Santanam U, Cimmino A, Palamarchuk A, Efanov A, Maximov V et al. (2006). Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res 66: 11590-11593.
147. Peter ME, Krammer PH. (2003). The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ 10: 26-35.
148. Pfeffer K, Matsuyama T, Kundig TM, Wakeham A, Kishihara K, Shahinian A et al. (1993). Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73: 457-467.
149. Plaisance V, Abderrahmani A, Perret-Menoud V, Jacquemin P, Lemaigre F, Regazzi R. (2006). MicroRNA-9 controls the expression of Granuphilin/Slp4and the secretory response of insulin-producing cells. J Biol Chem 281: 26932-26942.
150. Postigo AA, Dean DC. (1999). Independent repressor domains in ZEB regulate muscle and T-cell differentiation. Mol Cell Biol 19: 7961-7971.
151. Ramkissoon SH, Mainwaring LA, Ogasawara Y, Keyvanfar K, McCoy Jr JP, Sloand EM et al. (2006). Hematopoietic-specific microRNA expression in human cells. Leuk Res 30: 643-647.
152. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N et al. (2007). Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 26: 731-743.
153. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE et al. (2000). The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403: 901-906.
154. Ricci MS, Kim SH, Ogi K, Plastaras JP, Ling J, Wang W et al. (2007). Reduction of TRAIL-induced Mcl-1 and cIAP2 by c-Myc or sorafenib sensitizes resistant human cancer cells to TRAIL-induced death. Cancer Cell 12: 66-80.
155. Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR et al. (2007). Requirement of bic/microRNA-155 for normal immune function. Science 316: 608-611.
156. Roldo C, Missiaglia E, Hagan JP, Falconi M, Capelli P, Bersani S et al. (2006). MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 24: 4677-4684.
157. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P et al. (2000). Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 24: 227-235.
158. Salvesen GS, Duckett CS. (2002). IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 3: 401-410.
159. Sampson VB, Rong NH, Han J, Yang Q, Aris V, Soteropoulos P et al. (2007). MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res 67: 9762-9770.
160. Sarhadi VK, Wikman H, Salmenkivi K, Kuosma E, Sioris T, Salo J et al. (2006). Increased expression of high mobility group A proteins in lung cancer. J Pathol 209: 206-212.
161. Sathyan P, Golden HB, Miranda RC. (2007). Competing interactions between micro-RNAs determine neural progenitor survival and proliferation after ethanol exposure: evidence from an ex vivo model of the fetal cerebral cortical neuroepithelium. J Neurosci 27: 8546-8557.
162. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ et al. (1998). Two CD95 (APO-1/Fas) signaling pathways. EMBO J 17: 1675-1687.
163. Scaffidi C, Schmitz I, Krammer PH, Peter ME. (1999). The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem 274: 1541-1548.
164. Schmitz I, Krueger A, Baumann S, Schulze-Bergkamen H, Krammer PH, Kirchhoff S. (2003). An IL-2-dependent switch between CD95 signaling pathways sensitizes primary human T cells toward CD95-mediated activation-induced cell death. J Immunol 171: 2930-2936.
165. Schulman BR, Esquela-Kerscher A, Slack FJ. (2005). Reciprocal expression of lin-41 and the microRNAs let-7 and mir-125 during mouse embryogenesis. Dev Dyn 234: 1046-1054.
166. Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S, Peter ME. (1998). Apoptosis signaling by death receptors. Eur J Biochem 254: 439-459.
167. Sedger LM, Glaccum MB, Schuh JC, Kanaly ST, Williamson E, Kayagaki N et al. (2002). Characterization of the in vivo function of TNF-alpha-related apoptosis-inducing ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene-deficient mice. Eur J Immunol 32: 2246-2254.
168. Sethupathy P, Borel C, Gagnebin M, Grant GR, Deutsch S, Elton TS et al. (2007). Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3′ untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am J Hum Genet 81: 405-413.
169. Sevinsky JR, Whalen AM, Ahn NG. (2004). Extracellular signal-regulated kinase induces the megakaryocyte GPIIb/CD41 gene through MafB/Kreisler. Mol Cell Biol 24: 4534-4545.
170. Shell S, Park SM, Radjabi AR, Schickel R, Kistner EO, Jewell DA et al. (2007). Let-7 expression defines two differentiation stages of cancer. Proc Natl Acad Sci USA 104: 11400-11405.
171. Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY. (2007). miR-21-Mediated tumor growth. Oncogene 26: 2799-2803.
172. Singer GG, Abbas AK. (1994). The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1: 365-371.
173. Strasser A, Puthalakath H, O'Reilly LA, Bouillet P. (2008). What do we know about the mechanisms of elimination of autoreactive T and B cells and what challenges remain. Immunol Cell Biol 86: 57-66.
174. Sylvestre Y, De Guire V, Querido E, Mukhopadhyay UK, Bourdeau V, Major F et al. (2007). An E2F/miR-20a autoregulatory feedback loop. J Biol Chem 282: 2135-2143.
175. Szafranska AE, Davison TS, John J, Cannon T, Sipos B, Maghnouj A et al. (2007). MicroRNA expression alterations are linked to tumorigenesis and
176. Taganov KD, Boldin MP, Chang KJ, Baltimore D. (2006). NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 103: 12481-12486.
177. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H et al. (2004). Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64: 3753-3756.
178. Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, Menssen A et al. (2007). Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6: 1586-1593.
179. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD et al. (2008). Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451: 147-152.
180. Tazawa H, Tsuchiya N, Izumiya M, Nakagama H. (2007). Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci USA 104: 15472-15477.
181. Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y et al. (2007). Regulation of the germinal center response by microRNA-155. Science 316: 604-608.
182. Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B et al. (2007). Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 179: 5082-5089.
183. van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD et al. (2006). A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 103: 18255-18260.
184. Venturini L, Battmer K, Castoldi M, Schultheis B, Hochhaus A, Muckenthaler MU et al. (2007). Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. Blood 109: 4399-4405.
185. Versteeg R, Caron H, Cheng NC, van der Drift P, Slater R, Westerveld A et al. (1995). 1p36: every subband a suppressor? Eur J Cancer 31A: 538-541.
186. Viswanathan SR, Daley GQ, Gregory RI. (2008). Selective blockade of microRNA processing by Lin-28. Science 320: 97-100.
187. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261.
188. Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, Nagel R et al. (2006). A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124: 1169-1181.
189. Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, Nagel R et al. (2007). A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Adv Exp Med Biol 604: 17-46.
190. Waterhouse NJ, Sedelies KA, Browne KA, Wowk ME, Newbold A, Sutton VR et al. (2005). A central role for Bid in granzyme B-induced apoptosis. J Biol Chem 280: 4476-4482.
191. Weant AE, Michalek RD, Khan IU, Holbrook BC, Willingham MC, Grayson JM. (2008). Apoptosis regulators Bim and Fas function concurrently to control autoimmunity and CD8+ T cell contraction. Immunity 28: 218-230.
192. Welch C, Chen Y, Stallings RL. (2007). MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 26: 5017-5022.
193. Wightman B, Ha I, Ruvkun G. (1993). Posttranscriptional regulation of the heterochronic gene lin-14by lin-4mediates temporal pattern formation in C. elegans. Cell 75: 855-862.
194. Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, Wang J et al. (2007). MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131: 146-159.
195. Xu C, Lu Y, Pan Z, Chu W, Luo X, Lin H et al. (2007). The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J Cell Sci 120: 3045-3052.
196. Xu P, Vernooy SY, Guo M, Hay BA. (2003). The Drosophila microRNA Mir-14 suppress es cell death and is required for normal fat metabolism. Curr Biol 13: 790-795.
197. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M et al. (2006). Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198.
198. Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B et al. (2007). The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 13: 486-491.
199. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C et al. (2004). Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927-939.
200. Yasui DH, Genetta T, Kadesch T, Williams TM, Swain SL, Tsui LV et al. (1998). Transcriptional repression of the IL-2 gene in Th cells by ZEB. J Immunol 160: 4433-4440.
201. Yekta S, Shih IH, Bartel DP. (2004). MicroRNA-directed cleavage of HOXB8 mRNA. Science 304: 594-596.
202. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.
203. Zanette DL, Rivadavia F, Molfetta GA, Barbuzano FG, Proto-Siqueira R, Silva-Jr WA. (2007). miRNA Expression profiles in chronic lymphocytic and acute lymphocytic leukemia. Braz J Med Biol Res 40: 1435-1440.
204. Zeng Y. (2006). Principles of micro-RNA production and maturation. Oncogene 25: 6156-6162.
205. Zeng Y, Cullen BR. (2006). Recognition and cleavage of primary microRNA transcripts. Methods Mol Biol 342: 49-56.
206. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A et al. (2006). microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 103: 9136-9141.
207. Zhou B, Wang S, Mayr C, Bartel DP, Lodish HF. (2007). miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc Natl Acad Sci USA 104: 7080-7085.
208. Zhu S, Si ML, Wu H, Mo YY. (2007). MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282: 14328-14336.